Study to Evaluate Xtressé Gummy Supplement in Men With Androgenic Alopecia
Part of paid clinical trials in Maitland, Florida.
- Sponsor
- Restore Biologics Holdings, Inc. dba Xtressé
- Study ID
- NCT07637071
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Androgenic Alopecia
- Hair Loss/Baldness
- Hair Thinning
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Xtressé Hair Growth Gummies — OTHERThe nutraceutical supplement is powered by proprietary X-3 BioActive Blend and contains plant based extracts and regenerative compounds not commonly found in existing hair supplements.
Study Details
The goal of this study is to determine how safe and effective it is to improve hair growth using an active gummy treatment in men with androgenic alopecia. The main aims of this trial are: 1. To confirm using photographic analysis, changes in the quality, volume, and thickness of hair. 2. To gauge patient satisfaction with hair changes and application process. 3. Monitor and report any adverse events associated with the daily intake of Xtressé Participants who qualify will complete 3 visits after voluntary consent has been given. Participants will be given a 90-day supply of the gummies at visits 1 and 2 to cover the 6-month study period. Photographs and scalp analysis will be performed at each visit to measure changes in hair volume, thickness, and growth.
Key Dates
- Start date
- Jun 22, 2026
- Status verified
- Jun 2026
- Primary completion
- Jan 31, 2027
- Completion
- Mar 31, 2027
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Xtressé Nutraceutical Supplement ActiveXtressé Nutraceutical Supplement Participants will receive a 90 day supply of gummy supplement 2 times during the study. Participants will take supplement daily and notate usage in log.
Primary Outcome Measure
Within-subject increase in hair density assessed via Canfield HairMetrix® Phototrichogram Analysis [ Time Frame: From enrollment to the end of treatment at 6 months ]
Central Contacts
- Dr. Matt Leavitt, DO321-594-6851
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Advanced Dermatology & Cosmetic Surgery | Maitland | Florida | 32751 | Dr. Priya Pohani Matt Leavitt, DO (PRINCIPAL_INVESTIGATOR) |
| Advanced Dermatology & Cosmetic Surgery | Port Orange | Florida | 32127 | Charles Dunn, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Maitland, FL
Related Studies
- Evaluating the Combined Use of Supplement and Serum in Promoting Hair Growth in Women With Self-perceived Thinning HairRecruiting · The Center for Clinical and Cosmetic Research · Birmingham, Alabama
- Pilot Study to Evaluate the Efficacy and Safety of Xvie Delivered Into the Scalp by Microneedling in Women With Self-perceived Thinning HairEnrolling By Invitation · Restore Biologics Holdings, Inc. dba Xtressé · Maitland, Florida
- Study Evaluating Xtressé Gummy Supplement in Women With Self-Perceived Thinning HairEnrolling By Invitation · Restore Biologics Holdings, Inc. dba Xtressé · Maitland, Florida
- Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic AlopeciaEARLY_PHASE1 · Not Yet Recruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina